About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT07072026

Endovascular Recanalization for Symptomatic Chronic Intradural Occlusions

Background: Chronic intracranial large vessel occlusion (LVO), resulting from progressive atherosclerosis or thrombosis, contributes significantly to ischemic strokes, 8-10% in North America and up to...

Lead sponsor: Insel Gruppe AG, University Hospital Bern•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Petra Cimflova, MD, PhD

CONTACT

+41316640831 petra.cimflova@insel.ch

Jan Gralla, Prof. Dr. med.

CONTACT

+41316322654 jan.gralla@insel.ch

Sponsors

Lead Sponsor

Insel Gruppe AG, University Hospital Bern

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•all consecutive patients who undergone endovascular recanalization for chronic intradural large vessel occlusions between January 1st, 2020, and December 31st, 2024 involving the following locations: internal carotid artery (ICA), middle cerebral artery (MCA), vertebral artery (VA), and basilar artery (BA)

Exclusion Criteria

•presence of documented written or verbal refusal

Related studies

Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial

NCT04948749 · ICAD - Intracranial Atherosclerotic Disease, ICAS - Intracranial Atherosclerosis, and more

Enrolling By Invitation

Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome

NCT05583305 · Antiphospholipid Syndrome, Stenosis, and more

COMPLETEDPhase 3

Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease

NCT04142125 · Ischemic Stroke, Intracranial Atherosclerotic Disease

AcandiS Stenting of Intracranial STENosis - regisTry

NCT03902444 · Intracranial Stenosis

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 18, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment80

Start dateMay 2025

Last updatedJul 18, 2025

Condition

Intracranial Stenosis Intracranial Atherosclerotic Disease

Locations shown

Alfried Krupp Krankenhaus

Essen

Inselspital Bern, University Hospital Bern

Bern

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 18, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions